• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Elects New Board Officers for 2023

    Aspire Hires Darrec Jones as VP of Business Development

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected

    CRN Announces Promotions and Welcomes New Staff Member
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    GOED Elects New Board Officers for 2023

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Aspire Hires Darrec Jones as VP of Business Development

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    Quercetin Ingredient Linked to Improved COVID-19 Recovery: Study

    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    EIRICH Machines

    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Verdure Sciences

    Chenguang Biotech Group Co., Ltd.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    EIRICH Machines

    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Verdure Sciences

    Chenguang Biotech Group Co., Ltd.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    CBD in the Clinic: How Practitioners View Life After the Farm Bill

    Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.

    CBD in the Clinic: How Practitioners View Life After the Farm Bill
    Related Content
    • Sunflower Hemp Co
    • CRN: Clear Legal Plan & FDA Enforcement Can Ensure Safety & Benefits of CBD
    • Coalition Advocates for Declassification of Coconut as a ‘Tree Nut’ Allergen
    • Clearing Up Chaos in the Modern Nutraceuticals Market
    • CBD Regulatory Status Update: The Chaos Continues
    By Erik Goldman, Holistic Primary Care10.07.19
    Passage of the Farm Bill of 2018, and the concurrent FDA approval of Epidiolex—the first prescription drug derived from Cannabis sativa—were landmarks in the evolution of the market for cannabis and its popular derivative, cannabidiol (CBD).

    How are medical practitioners responding to these seismic changes? In Holistic Primary Care’s 2019 practitioner survey, we sought to find out.

    The survey—fielded last spring—included a suite of questions about CBD, cannabis, and hemp, and generated responses from 360 clinicians.

    Not surprisingly, the data indicated that CBD is very much a part of routine clinical practice in the world of holistic medicine, and that practitioners generally view it as effective.

    However, many expressed concerns about the influx of poorly made, spiked, or fraudulent products now flooding the market.

    At the same time, they’re also wary of the machinations of the pharmaceutical industry as it tries to stake its claims on cannabis therapeutics.

    A few quick demographics on the survey’s respondents: 32% are medical doctors, 15% are naturopaths, another 10% are osteopaths, 9% are nurses, and 7% are chiropractors. The remainder represented a wide range of practitioner sub-types, including acupuncturists, pharmacists, nutritionists, health coaches, and homeopaths.

    Nearly 70% are women, and the majority are in solo (49%) or small group (20%) practice settings.

    Nearly all (95%) take supplements and natural products for their own health, and 65% dispense products in their offices.

    Enthusiasm for CBD
    More than half of these practitioners—54% to be exact—currently recommend non-prescription CBD-containing products to their patients.

    Another 17% are using both prescription (Epidiolex) and non-prescription forms of CBD. However, none of our respondents are recommending prescription Epidiolex exclusively.

    An additional 15% indicated that while they are not currently recommending CBD to patients, they are considering it; 14% are not currently recommending and have no plans to do so.

    Notably, the conventionally-trained MDs in our cohort tracked very closely with the cohort as a whole in terms of their attitudes toward CBD.

    The top 10 conditions or disorders for which our practitioners are recommending CBD are as follows: chronic pain (86%); stress/anxiety (82%); insomnia/sleep problems (82%); low back pain (58%); headache (45%); depression (32%); GI problems (31%); menopausal Sx (22%); menstrual Sx (22%); multiple sclerosis (21%).

    Overall, they indicated that they find non-Rx CBD products to be effective for stress/anxiety (96%); insomnia & sleep problems (94%); chronic pain (94%); and headache (85%).

    The FDA’s approval of Epidiolex has had limited impact on our respondents’ views about the medical benefits of cannabis-based treatments. But that’s largely because most of them were already onboard with CBD and cannabis long before it became a pharmaceutical.

    More than two-thirds (69%) said they were already convinced of the therapeutic value of cannabis compounds prior to the approval of Epidiolex. Another 16% stated that while the approval did not thoroughly convince them of CBD’s medical value, they are now more willing to look at clinical research on CBD and other cannabinoids.

    And 13% said that approval of Epidiolex has made them more open to the medical value of cannabis.

    Impact of the Farm Bill
    Likewise, the 2018 Farm Bill—an historic piece of legislation widely lauded by industry as a legitimizing moment—has had limited, though significant, impact on holistic practitioners.

    More than half (52%) said they were already recommending hemp-derived medicines prior to passage of the Farm Bill last December. Another 24% indicated that the new law makes them more willing to recommend these products. In contrast, only 2% said they are less willing to recommend hemp products. Eighteen percent had no opinion about the Farm Bill.

    Given that HPC’s respondents are strongly self-identified as “holistic” or “functional” medicine practitioners, it’s not surprising that so many are already utilizing CBD in their clinics, or that the Epidiolex approval and the Farm Bill had limited impact on their attitudes.

    For the majority of our audience, cannabis and cannabis-derived substances needed no legitimization from governmental agencies. A cohort of more conservative mainstream doctors would probably have shown a different response pattern.

    Verbatim comments from our survey contained some valuable signals about the subtle but important ways the federal government’s moves are impacting day-to-day practice.

    One respondent wrote: “I was recommending (CBD) before. Since the passage of the Farm Bill I’m more comfortable carrying products in office.”

    Another suggested that the Farm Bill’s biggest impact may be on patients who’ve been curious but reluctant to try CBD.

    “The trickle-down effect is slow. I still have patients ‘fearful’ of hemp-based products, or working under government contracts prohibiting the use of any and all hemp-based products.”

    One thing is certain: our practitioners want more information about cannabis and CBD. This topic is tied with the microbiome for first place among subjects about which our readers most want to learn.

    Nearly two thirds (62%) of respondents indicated a desire for greater coverage of cannabis and CBD in Holistic Primary Care.

    Concerns About Over-Hype
    While our respondents generally view CBD as reliable and effective, some voiced a concern that the benefits are being over-hyped.

    “I am concerned Cannabis has been touted as a panacea. I’m sure it has benefits or it wouldn’t have been used for so many years. However, there are side effects and risks to everything, and these are not being considered or publicized carefully enough,” wrote one practitioner.

    Several others called for more research to substantiate the bold disease treatment and prevention claims or insinuations that have become prevalent in the marketplace, despite very clear FDA prohibitions against making such claims.

    There are other issues beyond product quality, unsubstantiated claims, and the potential for direct cannabis-associated adverse effects. One respondent pointed out that chronic, long-term use of CBD or other hemp-based substances may confound a practitioner’s ability to figure out what’s going on with a particular patient.

    “I find that the use of these products may obscure other clinical signs and progress, and interfere sometimes with the homeopathic medicines and the assessment of the response to them.”

    Wary of Big Pharma
    Many holistic practitioners—like many of their patients—are wary of the pharmaceutical industry. The Epidiolex approval struck many survey respondents as a brazen move on the part of Big Pharma to exploit an herb that it once vilified.

    A number of respondents voiced concern that the pharmaceutical-ization of cannabis will lead to higher prices, restriction of access, and ultimately exclusion of people who would potentially benefit from CBD and other cannabinoids.

    “Epidiolex is the pharma mafia’s fractionalized version of cannabis. What families with kids with epilepsy can afford $32,000 year and no insurance covering it? It is pure greed on big pharma’s part,” wrote one practitioner. “Cannabis is a vegetable and people should be able to grow their own!”

    There’s mistrust of the supplement industry as well. One respondent noted: “I am just as skeptical of nutraceutical companies as pharmaceutical companies. At least pharma has some regulation.”

    Isolates vs ‘Full Spectrum’
    Though the survey did not specifically include questions about preferences for CBD isolates compared to “full-spectrum” hemp oils, it is clear that this distinction is known to practitioners, and on the minds of some.

    “I think Epidiolex as a single CBD compound is Big Pharma’s way of getting in the Cannabis market and ignores the power of whole plant therapy.”

    But the reality is that, at this point in time, terms like “full-spectrum” and “whole-plant” are marketing language, not scientific definitions. No regulatory agency has published an official definition of “full spectrum” hemp.

    There’s a vague consensus within the supplement industry that the term signifies an extract of hemp leaves (not seeds) that contains a number of other naturally occurring cannabinoids in addition to CBD, but minimal levels of THC. But there’s no clear definition about which cannabinoids must be present in the “full spectrum” and in what quantity.

    Anthony Almada, a nutrition industry consultant who heads IMAGINutrition, noted that cannabis produces more than 1,000 unique chemicals, with more still to be characterized. Validated analytical methods have yet to be defined for most of the constituents of this plant.

    At most, the “full-spectrum” products currently on the market are testing for 30-40 chemical constituents.

    “They’re ‘full-spectrum’ by virtue of the limitations on what’s being tested,” Almada said at Holistic Primary Care’s 7th annual Practitioner Channel Forum.

    He likened hemp to wine grapes: one can predict the general chemical profile of a certain type of grape, but this profile changes depending on cultivation region, soil, weather conditions, harvesting and handling. The same is true for hemp, and really, for all herbs.

    This is one of the major distinctions between minimally processed herbal extracts, and highly purified single-constituent pharmaceuticals. Given the current state of regulations, CBD products blur that line: there’s the highly-purified prescription drug form (Epidiolex), and there are hundreds of products being sold as full-spectrum “CBD hemp oil” or variations of that wording.

    To varying degrees, CBD companies are insinuating therapeutic equivalence between their products and the prescription drug form. They often cite studies done with Epidiolex or other CBD isolates, to support their proposed benefits.

    Practitioners—especially those who have a lot of experience with cannabis—are aware of these distinctions. But their patients often are not, and this puts them in the position of having to educate their patients, and help them to separate the true signals from the noise.

    In general, Holistic Primary Care’s practitioner audience sees value in non-prescription CBD as a therapeutic tool. They have confidence in its efficacy for a range of common health concerns. It is up to the industry to continue earning that confidence, and to ensure that it is not betrayed. 


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, the nation’s leading conference focused on opportunities and challenges in the practitioner segment of the dietary supplement industry. 
    Related Searches
    • Kids
    • Extracts
    • Analytical Methods
    • Regulation
    Related Knowledge Center
    • Medical Nutrition
    • Herbs & Botanicals
    • Healthcare Trends
    • Dietary Supplements
    • Regulations
    • Quality & Safety
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    CRN: Clear Legal Plan & FDA Enforcement Can Ensure Safety & Benefits of CBD CRN: Clear Legal Plan & FDA Enforcement Can Ensure Safety & Benefits of CBD
    Coalition Advocates for Declassification of Coconut as a ‘Tree Nut’ Allergen Coalition Advocates for Declassification of Coconut as a ‘Tree Nut’ Allergen
    Clearing Up Chaos in the Modern Nutraceuticals Market Clearing Up Chaos in the Modern Nutraceuticals Market
    CBD Regulatory Status Update: The Chaos Continues CBD Regulatory Status Update: The Chaos Continues
    Clinical Nutrition: A New Market Opportunity Clinical Nutrition: A New Market Opportunity
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    Charlotte’s Web Introduces Hemp Extract-Infused Gummies Charlotte’s Web Introduces Hemp Extract-Infused Gummies
    EAS Assists Food & Hemp Firms with GRAS Submissions EAS Assists Food & Hemp Firms with GRAS Submissions
    Levagen PEA: A Legal Answer to CBD’s Issues Levagen PEA: A Legal Answer to CBD’s Issues
    Move Over Mainstream, Healthy Foods Are Here to Stay Move Over Mainstream, Healthy Foods Are Here to Stay
    Gencor Partners with Cannabis Researcher to Promote CBD Alternatives Gencor Partners with Cannabis Researcher to Promote CBD Alternatives
    BLIS M18 Probiotic Granted GRAS ‘No Objection’ Status BLIS M18 Probiotic Granted GRAS ‘No Objection’ Status

    Related Buyers Guide Companies

    • Sunflower Hemp Co

      ...
      Colby Terip, Owner 09.15.21

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      CRN: Clear Legal Plan & FDA Enforcement Can Ensure Safety & Benefits of CBD

      CRN: Clear Legal Plan & FDA Enforcement Can Ensure Safety & Benefits of CBD

      Association implores FDA to exercise statutory discretion.
      09.23.19

    • Breaking News | Industry & Market News | Quality & Safety | Regulations | World Markets
      Coalition Advocates for Declassification of Coconut as a ‘Tree Nut’ Allergen

      Coalition Advocates for Declassification of Coconut as a ‘Tree Nut’ Allergen

      Despite FDA guidance on allergen labeling, botanically, coconut is a fruit not a nut.
      09.10.19


    • Dietary Supplements | Healthcare Trends
      Clearing Up Chaos in the Modern Nutraceuticals Market

      Clearing Up Chaos in the Modern Nutraceuticals Market

      Demand for novel, holistic wellness solutions has pushed the industry in new territory.
      By Sean Moloughney, Editor 09.09.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Regulatory Status Update: The Chaos Continues

      CBD Regulatory Status Update: The Chaos Continues

      FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.
      By Todd Harrison, Venable 09.09.19

    Loading, Please Wait..
    Trending
    • Vitamin D Supplementation Reduces Risk Of Dynapenia
    • NOW Switches To Bottles Made From 100% Post-Consumer Recycled Resin
    • Study Examines Vitamin K2 Content In Cheese
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    Breaking News
    • GOED Elects New Board Officers for 2023
    • Aspire Hires Darrec Jones as VP of Business Development
    • Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    • BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    • CRN Announces Promotions and Welcomes New Staff Member
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MO SCI Acquires Assets of 3M’s Advanced Materials Business
    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly 4Q Revenues Down 9% to $7.3B
    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica Introduces Glow Baby Skincare Line
    Kohl’s Names Tom Kingsbury as Chief Executive Officer
    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Happi

    Latest Breaking News From Happi

    Grant Industries Names Mehran Ghadim Sales Manager, Canada
    Bio-Oil Celebrates Body Confidence Through Body Positivity Month Campaign
    Net Sales for Clorox Increase 1% for Q2 2023
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    MM Packaging adds first Nilpeter press for Dublin site
    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows
    Flex Recognized as One of Fortune World’s Most Admired Companies 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login